Tore Bach-Gansmo1, Trond V Bogsrud, Arne Skretting. 1. Department of Nuclear Medicine, Institute for Surgical Sciences, University of Bergen, Bergen, Norway. ingolv.tore.bach-gansmo@helse-bergen.no
Abstract
OBJECTIVE: Integrin scintimammography with NC100692 and a dedicated gamma-camera, LumaGEM, based on semi-conductor technology, was performed to investigate the detection ability of this combination in breast cancer. METHODS: Eight patients with a high suspicion of breast cancer were administered 600-750 MBq (99m)Tc-labelled NC100629. Two acquisitions using a cranio-caudal and a lateral view were used, with moderate compression of the breast. RESULTS: LumaGEM scintigraphy revealed 9 of 11 malignancies, sized 6-20 mm. Two lesions in patients with multicentric disease were not diagnosed, one of which measured only 2.5 mm. In one patient, the procedure was inconclusive, due to major breast hypertrophy. CONCLUSION: The combined use of NC100629 and a dedicated gamma-camera for breast imaging was highly effective in diagnosing breast cancer.
OBJECTIVE: Integrin scintimammography with NC100692 and a dedicated gamma-camera, LumaGEM, based on semi-conductor technology, was performed to investigate the detection ability of this combination in breast cancer. METHODS: Eight patients with a high suspicion of breast cancer were administered 600-750 MBq (99m)Tc-labelled NC100629. Two acquisitions using a cranio-caudal and a lateral view were used, with moderate compression of the breast. RESULTS: LumaGEM scintigraphy revealed 9 of 11 malignancies, sized 6-20 mm. Two lesions in patients with multicentric disease were not diagnosed, one of which measured only 2.5 mm. In one patient, the procedure was inconclusive, due to major breast hypertrophy. CONCLUSION: The combined use of NC100629 and a dedicated gamma-camera for breast imaging was highly effective in diagnosing breast cancer.
Authors: Irene Tsiapa; George Loudos; Eirini A Fragogeorgi; Penelope Bouziotis; Dimitrios Psimadas; Stavros Xanthopoulos; Maria Paravatou-Petsotas; Lazaros Palamaris; Alexandra D Varvarigou; Dimitris Karnabatidis; George C Kagadis Journal: Cancer Biother Radiopharm Date: 2014-12 Impact factor: 3.099
Authors: Matthew F Covington; Ephraim E Parent; Elizabeth H Dibble; Gaiane M Rauch; Amy M Fowler Journal: J Nucl Med Date: 2021-12-09 Impact factor: 11.082
Authors: Jason L J Dearling; Jessica W Barnes; Dipak Panigrahy; Robert E Zimmerman; Frederic Fahey; S Ted Treves; Matthew S Morrison; Mark W Kieran; Alan B Packard Journal: Nucl Med Biol Date: 2013-05-20 Impact factor: 2.408